Management of Turner Syndrome
Turner syndrome management requires a comprehensive multidisciplinary approach focusing on cardiovascular monitoring, growth hormone therapy, hormone replacement, and surveillance for associated conditions to reduce mortality and improve quality of life.
Cardiovascular Management
Cardiovascular complications are a major cause of mortality in Turner syndrome:
Initial Cardiovascular Assessment:
Risk Stratification and Monitoring:
- High risk: ASI ≥2.5 cm/m², history of aortic coarctation, or uncontrolled hypertension → annual evaluation 1
- Moderate risk: ASI 2.0-2.3 cm/m² → evaluation every 3-5 years 1
- Low risk: ASI <2.0 cm/m² → evaluation every 5-10 years 1
- Patients with no risk factors (no bicuspid valve, coarctation, or dilated aorta) → re-evaluation every 5-10 years 2
Interventions:
Growth Management
- Growth Hormone Therapy:
Reproductive and Hormonal Management
Estrogen Replacement Therapy:
Fertility Considerations:
Surveillance for Associated Conditions
Endocrine Disorders:
Other Systems:
Transition of Care
- Coordinated transition from pediatric to adult care is crucial to prevent loss of lifelong surveillance 1
- Adult patients should be followed by a multidisciplinary team including endocrinology, cardiology, gynecology, and other specialists as needed 5
Important Considerations and Pitfalls
- Diagnostic Delay: Despite characteristic features, average age at diagnosis is around 15 years 6, 7
- Cardiovascular Risk: Aortic dissection risk is significantly elevated (36:100,000 Turner syndrome years vs. 6:100,000 in general population) 2, 1
- Pregnancy Risks: Women with Turner syndrome face substantial risks during pregnancy and require specialized pre-conception counseling and monitoring 1
- Psychosocial Support: Patients may have normal intelligence but experience challenges with nonverbal, social, and psychomotor skills requiring appropriate support 4
Turner syndrome management requires vigilant lifelong monitoring with particular attention to cardiovascular risk, which represents the most significant threat to mortality in these patients.